Literature DB >> 17542439

Effect of diode laser retinal ablative therapy for threshold retinopathy of prematurity on the visual field: results of goldmann perimetry at a mean age of 11 years.

Eibhlin McLoone1, Michael O'Keefe, Sean McLoone, Bernadette Lanigan.   

Abstract

PURPOSE: To assess the peripheral visual field in premature children who received diode laser photocoagulation for threshold retinopathy of prematurity (ROP) and in a comparison group with subthreshold ROP that had regressed spontaneously without laser treatment. PATIENTS AND METHODS: Eleven patients (18 eyes) were treated with laser, and nine patients (16 eyes) with subthreshold untreated ROP were recalled for assessment at a mean follow-up of 11 years. All children underwent Goldmann visual field testing using the II4e and V4e stimuli. Distance visual acuity measurement, dilated fundal examination, and cycloplegic autorefraction were also performed.
RESULTS: The visual field extent in treated eyes was 3% to 4% smaller for the V4e target and 7% to 10% smaller for the II4e target than in the comparison eyes. For the II4e stimulus, the right eye visual field extent of the laser-treated children did not differ significantly from that of the untreated comparison group (P = .11), but the left eyes showed a borderline significant reduction (P = .046). For the larger V4e stimulus, no significant differences were noted (right eye, P = .41; left eye, P = .30).
CONCLUSIONS: This is the first study to assess the effect of diode laser therapy on the peripheral visual field in eyes with threshold ROP using Goldmann perimetry. Laser-treated eyes showed a slight constriction of peripheral visual fields compared with untreated subthreshold eyes. It is uncertain whether this was due to the laser treatment itself or to the more severe ROP in the laser group. However, the limited reduction in visual field extent is comparable to that reported for cryotherapy and is unlikely to be of functional significance.

Entities:  

Mesh:

Year:  2007        PMID: 17542439     DOI: 10.3928/0191-3913-20070301-10

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  9 in total

1.  Intravitreal bevacizumab in retinopathy of prematurity: an interventional case series.

Authors:  Ramak Roohipoor; Hamed Ghasemi; Fariba Ghassemi; Reza Karkhaneh; Mohammad Riazi-Esfahani; Mehdi Nili-Ahmadabadi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-15       Impact factor: 3.117

2.  Antecedents and correlates of visual field deficits in children born extremely preterm.

Authors:  Mari Holm; Michael E Msall; Jon Skranes; Olaf Dammann; Elizabeth Allred; Alan Leviton
Journal:  Eur J Paediatr Neurol       Date:  2014-10-12       Impact factor: 3.140

Review 3.  A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity.

Authors:  Laura Pertl; Gernot Steinwender; Christoph Mayer; Silke Hausberger; Eva-Maria Pöschl; Werner Wackernagel; Andreas Wedrich; Yosuf El-Shabrawi; Anton Haas
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

4.  Long term refractive and structural outcome following laser treatment for zone 1 aggressive posterior retinopathy of prematurity.

Authors:  Parag K Shah; Minu Ramakrishnan; Bani Sadat; Sandeep Bachu; V Narendran; N Kalpana
Journal:  Oman J Ophthalmol       Date:  2014-09

5.  Intravitreal bevacizumab as rescue therapy following treatment failure with laser photocoagulation in retinopathy of prematurity.

Authors:  Caner Kara; Emre Hekimoğlu; İkbal Seza Petriçli; Handan Akıl
Journal:  J Curr Ophthalmol       Date:  2017-08-24

6.  Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors.

Authors:  Fatemeh Bazvand; Hamid Riazi-Esfahani; Ahmad Mirshahi; Alireza Khodabande; Hasan Khojastheh; Afsar Dastjani Farahani; Ramak Roohipourmoallai; Marjan Imani; Hooshang Faghihi; Nazanin Ebrahimi Adib; Mohammadreza Mehrabi Bahar
Journal:  Int J Retina Vitreous       Date:  2021-01-11

7.  Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain.

Authors:  Shumpei Obata; Yusuke Ichiyama; Riko Matsumoto; Masashi Kakinoki; Yoshitsugu Saishin; Takahide Yanagi; Yoshihiro Maruo; Masahito Ohji
Journal:  PLoS One       Date:  2021-12-10       Impact factor: 3.240

Review 8.  Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP).

Authors:  Zijing Li; Yichi Zhang; Yunru Liao; Rui Zeng; Peng Zeng; Yuqing Lan
Journal:  BMC Ophthalmol       Date:  2018-01-30       Impact factor: 2.209

9.  Clinical Efficacy of Topical CoQ10 and Vitamin-E Eye-drop in Retinopathy of Prematurity.

Authors:  Muberra Akdogan; Onur Polat
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2019-10-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.